These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38336184)

  • 1. Identification of Erzhu Jiedu Recipe and its molecular mechanism underlying inhibited human hepatoma cells by UHPLC-Q-Exactive Orbitrap HRMS and network pharmacology.
    Wang F; Mai J; Wang H; Xu Y; Zhou X; Xie Z; Yu B; Liu P; Liu W; Cheng Y
    J Ethnopharmacol; 2024 May; 325():117893. PubMed ID: 38336184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Explore bioactive ingredients and potential mechanism of Houpo Mahuang decoction for chronic bronchitis based on UHPLC-Q exactive orbitrap HRMS, network pharmacology, and experiment verification.
    Gao F; Zhang T; Zhang H; Dai Z; Gu Y; Lu M; Zhang Z; Zeng Q; Shang B; Gao S; Wang N; Xu B; Lei H
    J Ethnopharmacol; 2023 Mar; 303():115924. PubMed ID: 36414217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia.
    Guo BJ; Ruan Y; Wang YJ; Xiao CL; Zhong ZP; Cheng BB; Du J; Li B; Gu W; Yin ZF
    J Integr Med; 2023 Sep; 21(5):474-486. PubMed ID: 37453868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of network pharmacology, UHPLC-Q exactive orbitrap HRMS technique and metabolomics to elucidate the active ingredients and mechanisms of compound danshen pills in treating hypercholesterolemic rats.
    Li S; An J; Zhang T; Chen G; Zhang Z; Guo Z; Dai Z; Cheng X; Cheng S; Xiong X; Wang N; Jiang G; Xu B; Lei H
    J Ethnopharmacol; 2025 Jan; 336():118759. PubMed ID: 39209003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Pharmacology-Based Strategy Combined with Molecular Docking and in vitro Validation Study to Explore the Underlying Mechanism of Huo Luo Xiao Ling Dan in Treating Atherosclerosis.
    Sun T; Quan W; Peng S; Yang D; Liu J; He C; Chen Y; Hu B; Tuo Q
    Drug Des Devel Ther; 2022; 16():1621-1645. PubMed ID: 35669282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of erzhu jiedu recipe on hepatitis B cirrhosis with hyperalphafetoproteinemia: A randomized, double-blind, placebo-controlled clinical trial.
    Chen TY; Mai JY; Zhang P; Xue JH; He SL; Xi J; Chen JJ; Cheng Y
    Medicine (Baltimore); 2021 Sep; 100(38):e27231. PubMed ID: 34559118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma.
    Huang J; Guo W; Cheung F; Tan HY; Wang N; Feng Y
    Am J Chin Med; 2020; 48(1):161-182. PubMed ID: 31964157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated multicomponent analysis based on ultra-high-performance liquid chromatography coupled with quadrupole-Exactive Orbitrap mass spectrometry and network pharmacology to elucidate the effective constituents and potential mechanism of Zhibai Dihuang pill in treating childhood precocious puberty.
    Zhang J; Yang Q; Wulu J; Zhang Z
    Rapid Commun Mass Spectrom; 2024 Aug; 38(16):e9831. PubMed ID: 38837506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the material basis and action mechanisms of sophora davidii (Franch.) skeels flower extract in the treatment of non-small cell lung cancer.
    Ye B; Chen P; Lin C; Zhang C; Li L
    J Ethnopharmacol; 2023 Dec; 317():116815. PubMed ID: 37400006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scutellaria barbata D.Don and Oldenlandia diffusa (Willd.) Roxb crude extracts inhibit hepatitis-B-virus-associated hepatocellular carcinoma growth through regulating circRNA expression.
    Yang PW; Chen TT; Zhao WX; Liu GW; Feng XJ; Wang SM; Pan YC; Wang Q; Zhang SH
    J Ethnopharmacol; 2021 Jul; 275():114110. PubMed ID: 33864890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A network pharmacology integrated serum pharmacochemistry strategy for uncovering efficacy of YXC on hepatocellular carcinoma.
    Zhou TT; Zhu WJ; Feng H; Ni Y; Li ZW; Sun DD; Li L; Tan JN; Yu CT; Shen WX; Cheng HB
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117125. PubMed ID: 37699493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
    Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
    Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.
    Yang X; Feng Y; Liu Y; Ye X; Ji X; Sun L; Gao F; Zhang Q; Li Y; Zhu B; Wang X
    Phytomedicine; 2021 Jul; 87():153575. PubMed ID: 33984593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology.
    Zhang C; Xiang H; Wang J; Shao G; Ding P; Gao Y; Xu H; Ji G; Wu T
    J Ethnopharmacol; 2023 Dec; 317():116676. PubMed ID: 37279814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
    Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
    J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
    Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
    J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating UPLC-Q-Exactive Orbitrap/MS, network pharmacology and experimental validation to reveal the potential mechanism of Tibetan medicine Rhodiola granules in improving myocardial ischemia-reperfusion injury.
    Xing N; Qin J; Ren D; Du Q; Li Y; Mi J; Zhang F; Ai L; Zhang S; Zhang Y; Wang S
    J Ethnopharmacol; 2023 Oct; 314():116572. PubMed ID: 37201662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis.
    Bi Y; Han X; Lai Y; Fu Y; Li K; Zhang W; Wang Q; Jiang X; Zhou Y; Liang H; Fan H
    J Ethnopharmacol; 2021 Oct; 278():114278. PubMed ID: 34087397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of UHPLC-Q Exactive-Orbitrap MS and network pharmacology to reveal the mechanism of Eucommia ulmoides leaves in the treatment of osteoarthritis.
    Liu T; Cao X; Cao D
    J Food Biochem; 2022 Aug; 46(8):e14204. PubMed ID: 35484881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of the toxicity-related quality markers and mechanisms of Zhi-Zi-Hou-Po decoction based on Chinmedomics combined with differentially absorbed components and network pharmacology.
    Wan S; Xie X; Yang G; Feng F
    J Ethnopharmacol; 2024 Feb; 320():117408. PubMed ID: 37972910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.